P

Porton Pharma Solutions Ltd
SZSE:300363

Watchlist Manager
Porton Pharma Solutions Ltd
SZSE:300363
Watchlist
Price: 24.84 CNY 3.72% Market Closed
Market Cap: 13.5B CNY

Intrinsic Value

The intrinsic value of one Porton Pharma Solutions Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 24.84 CNY, Porton Pharma Solutions Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Porton Pharma Solutions Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Porton Pharma Solutions Ltd

Intrinsic Value History
Dive into the past to invest in the future

Porton Pharma Solutions Ltd looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether Porton Pharma Solutions Ltd usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Porton Pharma Solutions Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Porton Pharma Solutions Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Porton Pharma Solutions Ltd.

Explain Valuation
Compare Porton Pharma Solutions Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Porton Pharma Solutions Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Porton Pharma Solutions Ltd

Current Assets 3.2B
Cash & Short-Term Investments 1.5B
Receivables 812.9m
Other Current Assets 857.5m
Non-Current Assets 5.5B
Long-Term Investments 347m
PP&E 4.1B
Intangibles 544m
Other Non-Current Assets 555.1m
Current Liabilities 1.7B
Accounts Payable 766.6m
Accrued Liabilities 150.4m
Short-Term Debt 48.5m
Other Current Liabilities 734.5m
Non-Current Liabilities 1.7B
Long-Term Debt 1.3B
Other Non-Current Liabilities 389.2m
Efficiency

Free Cash Flow Analysis
Porton Pharma Solutions Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Porton Pharma Solutions Ltd

Revenue
3.4B CNY
Cost of Revenue
-2.5B CNY
Gross Profit
956.4m CNY
Operating Expenses
-898.2m CNY
Operating Income
58.2m CNY
Other Expenses
-59.6m CNY
Net Income
-1.4m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Porton Pharma Solutions Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Sustainable 3Y Average Gross Margin
Healthy Gross Margin
Positive 3Y Average ROE
Low 3Y Average Operating Margin
hidden
Profitability
Score

Porton Pharma Solutions Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Porton Pharma Solutions Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
High Altman Z-Score
Short-Term Solvency
hidden
Solvency
Score

Porton Pharma Solutions Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Porton Pharma Solutions Ltd

Wall Street analysts forecast Porton Pharma Solutions Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Porton Pharma Solutions Ltd is 30.6 CNY with a low forecast of 30.3 CNY and a high forecast of 31.5 CNY.

Lowest
Price Target
30.3 CNY
22% Upside
Average
Price Target
30.6 CNY
23% Upside
Highest
Price Target
31.5 CNY
27% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Porton Pharma Solutions Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Porton Pharma Solutions Ltd stock?

The intrinsic value of one Porton Pharma Solutions Ltd stock under the Base Case scenario is hidden CNY.

Is Porton Pharma Solutions Ltd stock undervalued or overvalued?

Compared to the current market price of 24.84 CNY, Porton Pharma Solutions Ltd is hidden .

Back to Top